enGene Holdings Inc. announced the appointment of Lota S. Zoth, CPA, as a member of the Board of Directors and Audit Committee Chair. Ms. Zoth has more than two decades of experience in senior financial and accounting roles, including as Senior Vice President and Chief Financial Officer of MedImmune Inc. and Senior Vice President, Controller and Chief Accounting Officer of PSINet Inc. She also spent nearly a decade with Ernst Young leading auditing efforts for clients. Ms. Zoth is an experienced Board of Directors member, having served in various roles at other companies, including Board Chair, Lead Independent Director, and Audit Committee Chair, as well as on Compensation, Transaction, Finance and Special Strategic Committees.

She is currently serving on the Boards of the publicly traded companies Lumos Pharma, Inovio Pharmaceuticals, and 89 Bio. Her past Board experience includes Zymeworks, Spark Therapeutics, Aeras, Orexigen Therapeutics, Circassia Pharmaceuticals, Hyperion Therapeutics, and Ikaria.